Pereira Claudia Cristina de Aguiar, Torres Thiago Silva, Luz Paula Mendes, Hoagland Brenda, Farias Alessandro, Brito José David Urbaez, Lacerda Marcus Vinícius Guimarães, Silva Daila Alena Raenck, Benedetti Marcos, Pimenta Maria Cristina, Grinsztejn Beatriz, Veloso Valdilea Gonçalves
Escola Nacional de Saúde Pública Sérgio Arouca - ENSP, FIOCRUZ, Rio de Janeiro, RJ, Brazil.
Laboratório de Pesquisa Clínica em HIV/AIDS (LapClin-AIDS), Instituto Nacional de Infectologia Evandro Chagas - INI, FIOCRUZ, Rio de Janeiro, RJ, Brazil.
Lancet Reg Health Am. 2023 Feb 6;19:100432. doi: 10.1016/j.lana.2023.100432. eCollection 2023 Mar.
Men who have sex with men (MSM) and transgender women (TGW) are disproportionally affected by HIV infection in Latin America. This study aims to assess pre-exposure prophylaxis (PrEP) preferences among sexual and gender minorities (SGM) and identify attributes and levels that are related to PrEP uptake and adherence, both crucial for PrEP success.
We conducted a discrete choice experiment (DCE) among SGM from all Brazilian regions (September-December/2020). The survey was administered face-to-face (five Brazilian capitals) and online (entire country). We used a D-efficient zero-prior blocked experimental design to select 60 paired-profile DCE choice tasks.
The total sample size was 3924 (90.5% MSM; 7.2% TGW and 2.3% non-binary or gender diverse persons). In random-effects logit models, highest levels of protection and "no side effects" were the most important attribute levels. For "presentation", injectable and implant were preferred over oral. Participants were willing to accept a 4.1% protection reduction to receive injectable PrEP or a 4.2% reduction if PrEP were taken monthly. The largest class in the latent class models was defined predominantly by the preference for the highest HIV protection level (p < 0.005). Respondents in this class also preferred no side effects, injectable and implant presentations.
Higher HIV protection, no side effects, and presentation, whether injectable or implant, were the most important attributes in PrEP preferences. Protection against HIV was the most important attribute. PrEP programs should make available technologies such as long-acting presentations that could reunite the most desired attributes, thus maximizing acceptability and user-appropriateness.
Unitaid.
在拉丁美洲,男男性行为者(MSM)和跨性别女性(TGW)受艾滋病毒感染的影响尤为严重。本研究旨在评估性少数群体和性别少数群体(SGM)对暴露前预防(PrEP)的偏好,并确定与PrEP的采用和依从性相关的属性和水平,这两者对PrEP的成功都至关重要。
我们在巴西所有地区的SGM中开展了一项离散选择实验(DCE)(2020年9月至12月)。调查通过面对面(巴西五个首都)和在线(全国)方式进行。我们采用D效率零先验分组实验设计来选择60对配置文件的DCE选择任务。
总样本量为3924人(90.5%为MSM;7.2%为TGW,2.3%为非二元性别或性别多样化者)。在随机效应logit模型中,最高水平的保护和“无副作用”是最重要的属性水平。对于“剂型”,注射剂和植入剂比口服制剂更受青睐。参与者愿意接受保护水平降低4.1%以接受注射用PrEP,或如果每月服用PrEP则接受保护水平降低4.2%。潜在类别模型中的最大类别主要由对最高艾滋病毒保护水平的偏好定义(p < 0.005)。该类别的受访者也更喜欢无副作用、注射剂和植入剂剂型。
更高的艾滋病毒保护、无副作用以及剂型(无论是注射剂还是植入剂)是PrEP偏好中最重要的属性。预防艾滋病毒是最重要的属性。PrEP项目应提供长效剂型等技术,这些技术可以兼具最理想的属性,从而最大限度地提高可接受性和用户适用性。
国际药品采购机制(Unitaid)。